Industrials
SBC Medical Group Holdings Incorporated(SBC)
Live Price
Offline$3.00
+0.33% today
1Y Change
-30.88%
Window
Jun 23, 2025 โ Jun 17, 2026
- Market Cap
- $340.00M
- Revenue Growth
- -15.5%
- EPS Growth
- +3.6%
- Dividend Yield
- 0.0%
Coverage: 248 bars ยท Jun 23, 2025 โ Jun 17, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
SBC Medical Group Holdings Incorporated (SBC) is a Industrials stock with a market cap of $340.00M and listed on NASDAQ. The stock last traded around $3.00 and down 30.9% across the available one-year price window (Jun 23, 2025 โ Jun 17, 2026). Baseline metrics include revenue growth of -15.5%, EPS growth of +3.6%, a dividend yield of 0.0%. What stands out right now is revenue -15.5%, EPS +3.6%, free cash flow +112.8% with operating margin 38.9% and ROIC 12.6%. Valuation is more restrained than many high-expectation growth names at P/E 6.7 and price/sales 2.0. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines SBC price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Industrials peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Below sector median
-15.5% vs +3.6% peer median
Operating Margin
Above sector median
+38.9% vs +16.9% peer median
P/E
Below sector median
6.7 vs 36.7 peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on May 21, 2026, but the surprise data is still limited.
The operating picture looks softer than before
Revenue is at -15.5% and EPS is at +3.6%, with operating margin around 38.9%.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged +6.0% over the next 5 trading days and finished higher after 2 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 May 21, 2026 | โ | -1.0% | +3.5% | โ |
2026 Mar 27, 2026 | +7.7% | +3.3% | +14.4% | -14.6% |
2025 Nov 14, 2025 | -7.7% | -8.3% | +0.0% | +23.6% |
Benchmark Comparison
Normalized Performance vs SPY
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
SBC
โ
Normalized return
SPY
โ
S&P 500
Excess Return
โ
Relative to SPY
SBC Max Drawdown
-49.20%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for SBC and SPY.
Company Overview
SBC Medical Group Holdings Incorporated
NASDAQ Global Market
SBC Medical Group Holdings Incorporated provides management services to cosmetic treatment centers in Japan, Vietnam, the United States, and internationally. The company offers advertising and marketing services; staff management services, such as recruitment and training; booking reservations for franchisee clinic customers; assistance with franchisee employee housing rentals and facility rentals; construction and design of franchisee clinics; medical equipment; and medical consumables procurement. It provides IT software solutions; breast augmentation, liposuction, and rejuvenation treatments, including treatment of wrinkles, acne, scars, cellulite, excess fat, discoloration, and signs of aging; laser skin toning and spot removal; eyes double fold surgery; rhinoplasty; treatment of osmidrosis and hyperhidrosis; hair transplants; gynecological formation treatments; laser hair removal; face line surgeries; cosmetical dental procedures; tattoo removal; lasik eye surgery; lateral canthoplasty; brow lift procedures; androgenetic alopecia treatment; and cheek sagging prevention methods. The company was founded in 2000 and is headquartered in Irvine, California.
- Leadership
- Yoshiyuki Aikawa
- IPO Date
- Sep 26, 2022
- Employees
- 863
- Street Address
- 200 Spectrum Center Drive
- Mailing
- Irvine, CA, 92618
- Region
- Irvine, CA, US
- Reporting Currency
- USD
- Investor Line
- 949-593-0250
- Last Updated
- May 4, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- 6.7
- EV/EBITDA
- 2.9
- Price/Sales
- 2.0
- Price/Book
- 1.4
Growth
- Revenue
- -15.5%
- EPS
- +3.6%
- Free Cash Flow
- +112.8%
Profitability
- Gross Margin
- 72.9%
- Operating Margin
- 38.9%
- Net Margin
- 29.4%
- ROE
- 21.1%
- ROIC
- 12.6%
Balance Sheet
- Debt/Equity
- 0.21
- Current Ratio
- 3.78
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.